Richard E. Chaisson

Researcher Next ID · RN-024417

Researcher · Medicine

Johns Hopkins University

Baltimore, South Africa

Not currently recruitingFunding unknown

Works count: 503
Citation count: 42,917
H-index: 103
i10-index: 336

Research interests

Medicine

Tuberculosis Research and Epidemiology

Pneumocystis jirovecii pneumonia detection and treatment

HIV/AIDS Research and Interventions

HIV/AIDS drug development and treatment

Infectious Diseases and Tuberculosis

Publications

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2033400
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30024-8
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons
AIDS · 2016 · https://doi.org/10.1097/qad.0000000000001098
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Clinical Infectious Diseases · 2016 · https://doi.org/10.1093/cid/ciw376
Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)00323-2
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
European Respiratory Journal · 2015 · https://doi.org/10.1183/13993003.01245-2015
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1104875
New Regimens to Prevent Tuberculosis in Adults with HIV Infection
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1005136
Body mass index and risk of tuberculosis and death
AIDS · 2010 · https://doi.org/10.1097/qad.0b013e32833a2a4a
Tuberculosis and diabetes mellitus: convergence of two epidemics
The Lancet Infectious Diseases · 2009 · https://doi.org/10.1016/s1473-3099(09)70282-8
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort
AIDS · 2009 · https://doi.org/10.1097/qad.0b013e328327964f
Tuberculosis in Africa — Combating an HIV-Driven Crisis
New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmp0800809
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Nature Medicine · 1999 · https://doi.org/10.1038/8394

Current projects

No projects listed.